We are a leading healthcare campus encompassing all fields of health: from healthcare and research to teaching and management.
Professionalism, commitment and research by professionals on the Campus are the key elements in offering patients excellent care.
We are committed to research as a tool to provide solutions to the daily challenges we face in the field of medical healthcare.
We generate, transform and transmit knowledge in all areas of the health sciences, helping to train the professionals of the future.
We are defined by our vocation for communication. We invite you to share everything that happens at Vall d'Hebron Barcelona Hospital Campus, and our doors are always open.
Hospital donations
Research donations
Dr. Kevin P. Francis Ph.D, PerkinElmer Fellow and Visiting Professor at UCLA and Texas A&M / Dr. Guillaume Reveillon, PhD Field Application Specialist PerkinElmer
According to the World Health Organization, infectious diseases are estimated to cause a quarter of all deaths globally. Moreover, the risk of new pathogens emerging and evolving to monopolize on the ever-expanding global human population is increasing year-on-year. The recent COVID-19 viral pandemic, although devastating from both a social and economic standpoint, was relatively minor compared to prior viral and bacterial ‘plagues’ that have reshaped civilizations throughout history.
Each year more than 70 billion standard units of antibiotic are prescribed to treat bacterial infections worldwide. In addition, around 80,000 tons of antibiotics are consumed by livestock for growth promotion and disease prevention. The result of this overuse of antibiotics is a spiraling increase in resistance. Bacteria such as methicillin-resistant Staphylococcus aureus (MRSA) have increased in prevalence in hospitals over the last three decades. Such bacteria are particularly problematic in postoperative infections, exacerbating treatment through the development of biofilms, especially on medical implants which are extremely hard to treat without removal and replacement of the device.
This presentation will show how noninvasive preclinical optical imaging is being used to better understand the establishment and development of infections in a range of different animal disease models, including post-operative infections
Host: Dr. Anna Santamaria, Biomedical Research in Urology group.
Online Connection: https://gencat.zoom.us/j/94191432677
Select the newsletter you want to receive:
By accepting these conditions, you are agreeing to the processing of your personal data for the provision of the services requested through this portal, and, if necessary, for any procedures required by the administrations or public bodies involved in this processing, and their subsequent inclusion in the aforementioned automated file. You may exercise your rights to access, rectification, cancellation or opposition by writing to web@vallhebron.cat, clearly stating the subject as "Exercising of Data Protection Rights". Operated by: Vall d’Hebron University Hospital Foundation – Research Institute. Purpose: Manage the user’s contact information. Legitimisation: Express acceptance of the privacy policy. Rights: To access, rectify, and delete personal information data, as well to the portability thereof and to limit and/or oppose their use. Source: The interested party themselves.